Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • MIB Agents’ Community of Families Has Awarded Over $1.5M in Grants to Research Pediatric Bone Cancer

    Jun 15, 2023, 09:30 AM by
    MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.
    Full story
  • Unique molecule life cycle platform released: Torx® 2.0

    Jun 14, 2023, 10:14 AM by
    Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.
    Full story
  • Cancer Gene Therapy | Current Insight with Future Aspect Analysis

    Jun 14, 2023, 10:14 AM by
    The global cancer gene therapy industry size accounted for USD 2.04 billion in 2022 and is estimated to achieve a market size of USD 12.75 billion by 2032 growing at a CAGR of 20.1% from 2023 to 2032.
    Full story
  • N-Lorem Foundation Bringing Real Hope To ‘N-Of-1’ Patients

    Jun 14, 2023, 01:00 AM by User Not Found
    Bio-IT World | Stanley T. Crooke, M.D., Ph.D., founder and longtime leader of the company that pioneered RNA-targeted therapeutics, is now chairman and CEO of the n-Lorem Foundation descaling the technology to treat patients helpless before a healthcare system that wasn’t built for “n-of-1” problems. He will be addressing a room of physicians and scientists tomorrow on the campus of Vanderbilt University.
    Full story
  • Sygnature Discovery launches its LPS in vivo model to profile early-stage anti-inflammatory drugs

    Jun 13, 2023, 12:58 PM by
    Full story
  • 70% Of Major Pharmaceutical Companies And CROs Surveyed Have Adopted Digital Pathology

    Jun 13, 2023, 12:58 PM by
    Report reveals initial deployment of legacy systems has paved the way for imminent shift to modern software needed to accelerate AI-powered drug R&D
    Full story
  • Kalderos' 2023 annual report highlights costs of systemic challenges in drug discount programs and their impact on drug manufacturers, covered entities, payers and patients

    Jun 13, 2023, 12:58 PM by
    Kalderos’ 2023 annual report highlights costs of systemic challenges in drug discount programs and their impact on drug manufacturers, covered entities, payers and patients
    Full story
  • James Rickard appointed Chief Scientific Officer of Richmond Research Institute

    Jun 13, 2023, 12:58 PM by
    Full story
  • CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research

    Jun 13, 2023, 12:58 PM by
    Full story
  • Science Diplomats Sound the Alarm for Resiliency Preparedness at BIO Convention

    Jun 13, 2023, 01:00 AM by User Not Found
    Bio-IT World | BOSTON—The largest biotechnology conference in the world, the BIO International Conference, convened in Boston this week drawing over 20,000 attendees from more than 60 countries. In our post-pandemic world, the common thread throughout the conference was the need for global collaboration on our scientific challenges.
    Full story
  • Illumina CEO Resigns

    Jun 12, 2023, 10:57 AM by User Not Found
    Bio-IT World | Illumina announced yesterday that Francis deSouza, Illumina's Chief Executive Officer and a Director, has resigned, effective Sunday, June 11.
    Full story
  • Global Cellular Health Screening Market was valued at $2.6 billion in 2022 and is set to witness a CAGR of 9% by 2027 - Growing Applications in Personalized Medicine

    Jun 8, 2023, 10:50 AM by
    Government initiatives towards preventive healthcare, growing funding & investments in R&D activities, adoption of direct-to-consumer approach, increasing applications in personalized medicine and growing burden of chronic diseases are some of the major factors driving the growth of cellular health screening market.
    Full story
  • CallDeflectAI Helps Address Staff Shortages in Contact Centers

    Jun 8, 2023, 10:50 AM by
    Full story
  • BullFrog AI Strengthens Capabilities of its AI Platform Through Expansion of Licensing Agreement With Johns Hopkins Applied Physics Laboratory

    Jun 8, 2023, 10:50 AM by
    Full story
  • AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology

    Jun 8, 2023, 10:50 AM by
    AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology Integration of AARDEX MEMS AS and MEMS Mobile technology with Mevia's Medose dispenser offers opportunity to pilot next stage in reusable and real-time adherence solutions.
    Full story
  • Purolite Grows Bioprocessing Production Capacity with New U.S. Manufacturing Facility

    Jun 8, 2023, 10:50 AM by
    Landenberg site strengthens supply to support lifesaving therapeutics for global customers
    Full story
  • Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio

    Jun 8, 2023, 10:50 AM by
    Full story
  • Yeast Protein Expression Process

    Jun 8, 2023, 10:50 AM by
    Full story
  • Qlucore presents promising results in the field of lung cancer diagnosis

    Jun 8, 2023, 10:48 AM by
    Qlucore, listed on Nasdaq First North, can now present the first results from an EU-funded project for improved diagnosis of lung cancer. The new classification model not only separates different subgroups of primary lung cancer but also indicates whether the tumor sample is a metastasis of breast, colorectal, or kidney cell cancer.
    Full story
  • Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden

    Jun 8, 2023, 10:48 AM by
    Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden Strategic partnership integrates next-generation patient support and payment solutions for participants and sites alike
    Full story
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86 (current)
  • 87
  • 88
  • 89
  • 90
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy